Biosimilar CT-P13 Can Safely Replace Much More Expensive Remicade as RA Treatment, Study Finds
News
Rheumatoid arthritis (RA) patients taking Remicade (infliximab) can safely switch to CT-P13 (developed by Celltrion) — a much cheaper biosimilar of Remicade ... Read more